420 related articles for article (PubMed ID: 1676897)
1. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
[TBL] [Abstract][Full Text] [Related]
2. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.
Noronha IL; Daniel V; Schimpf K; Opelz G
Clin Exp Immunol; 1992 Feb; 87(2):287-92. PubMed ID: 1735193
[TBL] [Abstract][Full Text] [Related]
3. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS.
Reddy MM; McKinley G; Englard A; Grieco MH
Int J Immunopharmacol; 1990; 12(7):737-41. PubMed ID: 2127261
[TBL] [Abstract][Full Text] [Related]
4. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
5. Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children.
Arditi M; Kabat W; Yogev R
Pediatr Infect Dis J; 1991 Jun; 10(6):450-5. PubMed ID: 1677177
[TBL] [Abstract][Full Text] [Related]
6. Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations.
Reddy MM; Grieco MH
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):115-20. PubMed ID: 2966633
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases.
Honda M; Kitamura K; Mizutani Y; Oishi M; Arai M; Okura T; Igarahi K; Yasukawa K; Hirano T; Kishimoto T
J Immunol; 1990 Dec; 145(12):4059-64. PubMed ID: 2258606
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of human immunodeficiency virus in vertically infected infants and children.
Alimenti A; Luzuriaga K; Stechenberg B; Sullivan JL
J Pediatr; 1991 Aug; 119(2):225-9. PubMed ID: 1677684
[TBL] [Abstract][Full Text] [Related]
10. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
11. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
12. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection.
Croxson TS; Mathur-Wagh U; Handwerger S; Siroty WE; Kaminisky D; Reagan KJ; Yancovitz SR; Mildvan D
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):455-63. PubMed ID: 2111160
[TBL] [Abstract][Full Text] [Related]
14. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
Mulder JW; Lange JM; de Wolf F; Houweling JT; Bakker M; Coutinho RA; Goudsmit J
Neth J Med; 1990 Aug; 37(1-2):4-10. PubMed ID: 2120599
[TBL] [Abstract][Full Text] [Related]
15. CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms.
Orholm M; Nielsen TL; Nielsen JO; Lundgren JD
AIDS; 1990 Feb; 4(2):163-6. PubMed ID: 1970256
[TBL] [Abstract][Full Text] [Related]
16. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.
Ciardi M; Sharief MK; Thompson EJ; Salotti A; Vullo V; Sorice F; Cirelli A
J Neurol Sci; 1994 Sep; 125(2):175-9. PubMed ID: 7807163
[TBL] [Abstract][Full Text] [Related]
17. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection.
von Sydow M; Sönnerborg A; Gaines H; Strannegård O
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):375-80. PubMed ID: 1906289
[TBL] [Abstract][Full Text] [Related]
19. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis.
Madson KL; Moore TL; Lawrence JM; Osborn TG
J Rheumatol; 1994 Dec; 21(12):2359-63. PubMed ID: 7699643
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
